{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:20:55Z","timestamp":1788909655468,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10096-024-04956-y","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T22:01:32Z","timestamp":1728338492000},"page":"2397-2406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of different standard and modified two-tier testing strategies for the laboratory diagnosis of lyme borreliosis in a European setting"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3872-3437","authenticated-orcid":false,"given":"B. J. A.","family":"Hoeve-Bakker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2208-9902","authenticated-orcid":false,"given":"K.","family":"Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-8652","authenticated-orcid":false,"given":"M.","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8411-1653","authenticated-orcid":false,"given":"S. F. T.","family":"Thijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-5902","authenticated-orcid":false,"given":"T.","family":"van Gorkom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"issue":"3","key":"4956_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/femsre\/fux047","volume":"42","author":"G Stanek","year":"2018","unstructured":"Stanek G, Strle F (2018) Lyme borreliosis-from tick bite to diagnosis and treatment. FEMS Microbiol Rev 42(3):233\u2013258. https:\/\/doi.org\/10.1093\/femsre\/fux047","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"4956_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.medmal.2018.11.011","volume":"49","author":"C Eldin","year":"2019","unstructured":"Eldin C et al (2019) Review of European and American guidelines for the diagnosis of Lyme borreliosis. Med Mal Infect 49(2):121\u2013132. https:\/\/doi.org\/10.1016\/j.medmal.2018.11.011","journal-title":"Med Mal Infect"},{"key":"4956_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12879-016-1468-4","volume":"16","author":"MM Leeflang","year":"2016","unstructured":"Leeflang MM et al (2016) The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. BMC Infect Dis 16:140. https:\/\/doi.org\/10.1186\/s12879-016-1468-4","journal-title":"BMC Infect Dis"},{"key":"4956_CR4","doi-asserted-by":"publisher","unstructured":"Pegalajar-Jurado A et al (2018) Evaluation of modified two-tiered testing algorithms for lyme disease laboratory diagnosis using well-characterized serum samples. J Clin Microbiol 56 (8). https:\/\/doi.org\/10.1128\/jcm.01943-17","DOI":"10.1128\/jcm.01943-17"},{"issue":"5","key":"4956_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.14745\/ccdr.v46i05a05","volume":"46","author":"TF Hatchette","year":"2020","unstructured":"Hatchette TF (2020) Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context. Can Commun Dis Rep 46(5):125\u2013131. https:\/\/doi.org\/10.14745\/ccdr.v46i05a05","journal-title":"Can Commun Dis Rep"},{"issue":"32","key":"4956_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","volume":"68","author":"P Mead","year":"2019","unstructured":"Mead P et al (2019) Updated CDC recommendation for serologic diagnosis of lyme disease. MMWR Morb Mortal Wkly Rep 68(32):703. https:\/\/doi.org\/10.15585\/mmwr.mm6832a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"4956_CR7","doi-asserted-by":"publisher","first-page":"e0102021","DOI":"10.1128\/Spectrum.01020-21","volume":"9","author":"M Markowicz","year":"2021","unstructured":"Markowicz M et al (2021) Persistent anti-borrelia igm antibodies without lyme borreliosis in the clinical and immunological context. Microbiol Spectr 9(3):e0102021. https:\/\/doi.org\/10.1128\/Spectrum.01020-21","journal-title":"Microbiol Spectr"},{"issue":"6","key":"4956_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1086\/322669","volume":"33","author":"RA Kalish","year":"2001","unstructured":"Kalish RA et al (2001) Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10\u201320 years after active Lyme disease. Clin Infect Dis 33(6):780\u2013785. https:\/\/doi.org\/10.1086\/322669","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4956_CR9","doi-asserted-by":"publisher","first-page":"e0051022","DOI":"10.1128\/spectrum.00510-22","volume":"10","author":"BJA Hoeve-Bakker","year":"2022","unstructured":"Hoeve-Bakker BJA et al (2022) The performance of nine commercial serological screening assays for the diagnosis of lyme borreliosis: a multicenter modified two-gate design study. Microbiol Spectr 10(2):e0051022. https:\/\/doi.org\/10.1128\/spectrum.00510-22","journal-title":"Microbiol Spectr"},{"issue":"11","key":"4956_CR10","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s10096-020-03946-0","volume":"39","author":"ME Baarsma","year":"2020","unstructured":"Baarsma ME et al (2020) Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease. Eur J Clin Microbiol Infect Dis 39(11):2143\u20132152. https:\/\/doi.org\/10.1007\/s10096-020-03946-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"4956_CR11","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s10096-017-3037-1","volume":"36","author":"T van Gorkom","year":"2017","unstructured":"van Gorkom T et al (2017) Disagreement between the results from three commercial tests for the detection of Borrelia-specific serum antibodies in the Netherlands associated with antibiotic treatment for Lyme borreliosis: a retrospective study. Eur J Clin Microbiol Infect Dis 36(11):2137\u20132146. https:\/\/doi.org\/10.1007\/s10096-017-3037-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"4956_CR12","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1373\/clinchem.2005.048595","volume":"51","author":"AW Rutjes","year":"2005","unstructured":"Rutjes AW et al (2005) Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem 51(8):1335\u20131341. https:\/\/doi.org\/10.1373\/clinchem.2005.048595","journal-title":"Clin Chem"},{"issue":"12","key":"4956_CR13","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1373\/clinchem.2015.246280","volume":"61","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem 61(12):1446\u20131452. https:\/\/doi.org\/10.1373\/clinchem.2015.246280","journal-title":"Clin Chem"},{"issue":"1","key":"4956_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A et al (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(1):8-16.e11-14. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02862.x","journal-title":"Eur J Neurol"},{"key":"4956_CR15","unstructured":"Team RC (2023) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria. https:\/\/www.R-project.org\/. Accessed 27 Oct 2023"},{"key":"4956_CR16","unstructured":"Doebler P (2015) Meta-analysis of diagnostic accuracy with mada. R Packages. https:\/\/api.semanticscholar.org\/CorpusID:30459830. Accessed 27 Oct 2023"},{"issue":"11","key":"4956_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","volume":"56","author":"AS Glas","year":"2003","unstructured":"Glas AS et al (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56(11):1129\u20131135. https:\/\/doi.org\/10.1016\/S0895-4356(03)00177-X","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"4956_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"2018","unstructured":"Benjamini Y, Hochberg Y (2018) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57(1):289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"3","key":"4956_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.diagmicrobio.2012.04.001","volume":"73","author":"L Busson","year":"2012","unstructured":"Busson L et al (2012) Evaluation of commercial screening tests and blot assays for the diagnosis of Lyme borreliosis. Diagn Microbiol Infect Dis 73(3):246\u2013251. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.04.001","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"4956_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/jcm.01841-19","volume":"58","author":"IRC Davis","year":"2020","unstructured":"Davis IRC et al (2020) Performance of a modified two-tiered testing enzyme immunoassay algorithm for serologic diagnosis of lyme disease in Nova Scotia. J Clin Microbiol 58(7):10\u20131128. https:\/\/doi.org\/10.1128\/jcm.01841-19","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4956_CR21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/microorganisms11041081","volume":"11","author":"BJA Hoeve-Bakker","year":"2023","unstructured":"Hoeve-Bakker BJA et al (2023) Seroprevalence and risk factors of lyme borreliosis in The Netherlands: a population-based cross-sectional study. Microorganisms 11(4):1081. https:\/\/doi.org\/10.3390\/microorganisms11041081","journal-title":"Microorganisms"},{"issue":"6","key":"4956_CR22","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10096-020-04093-2","volume":"40","author":"H Hillerdal","year":"2021","unstructured":"Hillerdal H, Henningsson AJ (2021) Serodiagnosis of Lyme borreliosis-is IgM in serum more harmful than helpful? Eur J Clin Microbiol Infect Dis 40(6):1161\u20131168. https:\/\/doi.org\/10.1007\/s10096-020-04093-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4956_CR23","unstructured":"CBO (2013) [Dutch Guideline Lyme Disease], https:\/\/www.rivm.nl\/nieuws\/cbo-richtlijn-lymeziekte-definitief. Accessed: 15\u201309\u20132021"},{"issue":"4","key":"4956_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10096-021-04366-4","volume":"41","author":"G Joyner","year":"2022","unstructured":"Joyner G et al (2022) Introduction of IgM testing for the diagnosis of acute Lyme borreliosis: a study of the benefits, limitations and costs. Eur J Clin Microbiol Infect Dis 41(4):671\u2013675. https:\/\/doi.org\/10.1007\/s10096-021-04366-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"4956_CR25","doi-asserted-by":"publisher","first-page":"115782","DOI":"10.1016\/j.diagmicrobio.2022.115782","volume":"104","author":"A Pietikainen","year":"2022","unstructured":"Pietikainen A et al (2022) Borrelia burgdorferi specific serum and cerebrospinal fluid antibodies in Lyme neuroborreliosis. Diagn Microbiol Infect Dis 104(3):115782. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115782","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"4956_CR26","doi-asserted-by":"publisher","first-page":"1500.e1501","DOI":"10.1016\/j.cmi.2022.06.001","volume":"28","author":"MM Tetens","year":"2022","unstructured":"Tetens MM et al (2022) The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study. Clin Microbiol Infect 28(11):1500.e1501-1500.e1506. https:\/\/doi.org\/10.1016\/j.cmi.2022.06.001","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"4956_CR27","doi-asserted-by":"publisher","first-page":"e0006122","DOI":"10.1128\/spectrum.00061-22","volume":"10","author":"T van Gorkom","year":"2022","unstructured":"van Gorkom T et al (2022) Retrospective evaluation of various serological assays and multiple parameters for optimal diagnosis of lyme neuroborreliosis in a routine clinical setting. Microbiol Spectr 10(3):e0006122. https:\/\/doi.org\/10.1128\/spectrum.00061-22","journal-title":"Microbiol Spectr"},{"issue":"3","key":"4956_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10096-021-04372-6","volume":"41","author":"ME Baarsma","year":"2022","unstructured":"Baarsma ME et al (2022) Diagnostic performance of the ZEUS Borrelia VlsE1\/pepC10 assay in European LB patients: a case-control study. Eur J Clin Microbiol Infect Dis 41(3):387\u2013393. https:\/\/doi.org\/10.1007\/s10096-021-04372-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"4956_CR29","doi-asserted-by":"publisher","first-page":"ofac272","DOI":"10.1093\/ofid\/ofac272","volume":"9","author":"F Khan","year":"2022","unstructured":"Khan F et al (2022) Modified two-tiered testing enzyme immunoassay algorithm for serologic diagnosis of lyme disease. Open Forum Infect Dis 9(7):ofac272. https:\/\/doi.org\/10.1093\/ofid\/ofac272","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"4956_CR30","doi-asserted-by":"publisher","first-page":"e0252821","DOI":"10.1128\/jcm.02528-21","volume":"60","author":"MM Sfeir","year":"2022","unstructured":"Sfeir MM et al (2022) Multicenter clinical evaluation of modified two-tiered testing algorithms for lyme disease using zeus scientific commercial assays. J Clin Microbiol 60(5):e0252821. https:\/\/doi.org\/10.1128\/jcm.02528-21","journal-title":"J Clin Microbiol"},{"issue":"7","key":"4956_CR31","doi-asserted-by":"publisher","first-page":"e0320520","DOI":"10.1128\/jcm.03205-20","volume":"59","author":"ME Baarsma","year":"2021","unstructured":"Baarsma ME et al (2021) Diagnostic performance of the novel BioPlex lyme serological assays in European patients with lyme disease. J Clin Microbiol 59(7):e0320520. https:\/\/doi.org\/10.1128\/jcm.03205-20","journal-title":"J Clin Microbiol"},{"issue":"Pt 3","key":"4956_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1099\/jmm.0.000009","volume":"64","author":"RB Dessau","year":"2015","unstructured":"Dessau RB et al (2015) Multiplex assay (Mikrogen recomBead) for detection of serum IgG and IgM antibodies to 13 recombinant antigens of Borrelia burgdorferi sensu lato in patients with neuroborreliosis: the more the better? J Med Microbiol 64(Pt 3):224\u2013231. https:\/\/doi.org\/10.1099\/jmm.0.000009","journal-title":"J Med Microbiol"},{"issue":"2","key":"4956_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.diagmicrobio.2018.12.001","volume":"94","author":"LE Nigrovic","year":"2019","unstructured":"Nigrovic LE et al (2019) Higher C6 enzyme immunoassay index values correlate with a diagnosis of noncutaneous Lyme disease. Diagn Microbiol Infect Dis 94(2):160\u2013164. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.12.001","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04956-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04956-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04956-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T09:04:28Z","timestamp":1732957468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04956-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4956"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04956-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study \u201cT-cell response in Lyme\u201d (TRIL) was approved by the regional Medical Research Ethics Committees United (MEC-U), Nieuwegein, The Netherlands and registered with the Central Committee on Research Involving Human Subjects (CCMO) of the Netherlands under number NL36407.100.11 at 09\u201307-2020.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the TRIL study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}